Is increased myocardial triglyceride content associated with early changes in left ventricular function? A 1H-MRS and MRI strain study

Front Endocrinol (Lausanne). 2023 Jun 22:14:1181452. doi: 10.3389/fendo.2023.1181452. eCollection 2023.

Abstract

Background: Type 2 diabetes (T2D) and obesity induce left ventricular (LV) dysfunction. The underlying pathophysiological mechanisms remain unclear, but myocardial triglyceride content (MTGC) could be involved.

Objectives: This study aimed to determine which clinical and biological factors are associated with increased MTGC and to establish whether MTGC is associated with early changes in LV function.

Methods: A retrospective study was conducted using five previous prospective cohorts, leading to 338 subjects studied, including 208 well-phenotyped healthy volunteers and 130 subjects living with T2D and/or obesity. All the subjects underwent proton magnetic resonance spectroscopy and feature tracking cardiac magnetic resonance imaging to measure myocardial strain.

Results: MTGC content increased with age, body mass index (BMI), waist circumference, T2D, obesity, hypertension, and dyslipidemia, but the only independent correlate found in multivariate analysis was BMI (p=0.01; R²=0.20). MTGC was correlated to LV diastolic dysfunction, notably with the global peak early diastolic circumferential strain rate (r=-0.17, p=0.003), the global peak late diastolic circumferential strain rate (r=0.40, p<0.0001) and global peak late diastolic longitudinal strain rate (r=0.24, p<0.0001). MTGC was also correlated to systolic dysfunction via end-systolic volume index (r=-0.34, p<0.0001) and stroke volume index (r=-0.31, p<0.0001), but not with longitudinal strain (r=0.009, p=0.88). Interestingly, the associations between MTGC and strain measures did not persist in multivariate analysis. Furthermore, MTGC was independently associated with LV end-systolic volume index (p=0.01, R²=0.29), LV end-diastolic volume index (p=0.04, R²=0.46), and LV mass (p=0.002, R²=0.58).

Conclusions: Predicting MTGC remains a challenge in routine clinical practice, as only BMI independently correlates with increased MTGC. MTGC may play a role in LV dysfunction but does not appear to be involved in the development of subclinical strain abnormalities.

Trial registration: ClinicalTrials.gov NCT01284816 NCT02042664 NCT03118336.

Keywords: cardiac magnetic resonance imaging; feature-tracking; left ventricular function; myocardial strain; myocardial triglyceride content; obesity; type 2 diabetes.

MeSH terms

  • Diabetes Mellitus, Type 2* / diagnostic imaging
  • Humans
  • Magnetic Resonance Imaging
  • Obesity / complications
  • Obesity / diagnostic imaging
  • Proton Magnetic Resonance Spectroscopy
  • Retrospective Studies
  • Triglycerides
  • Ventricular Dysfunction, Left* / pathology
  • Ventricular Function, Left / physiology

Substances

  • Triglycerides

Associated data

  • ClinicalTrials.gov/NCT01284816
  • ClinicalTrials.gov/NCT02042664
  • ClinicalTrials.gov/NCT03118336